Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
25.4%
% of XBI's 131 holdings also in CNCR
44.0%
% of CNCR's 75 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 1.3% | 1.5% | 1.3% |
|
EXELIXIS INC | 1.2% | 1.4% | 1.2% |
|
GERON CORP | 1.1% | 3.0% | 1.1% |
|
BLUEPRINT MEDICINES CORP. | 1.1% | 1.4% | 1.1% |
|
REGENERON PHARMACEUTICALS | 1.1% | 1.3% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CNCR
|
NIVALIS THERAPEUTICS INC | 1.9% |
|
BIOMARIN PHARMACEUTICAL INC | 1.2% |
|
CYTOKINETICS INC | 1.2% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 1.2% |
|
CRINETICS PHARMACEUTICALS INC | 1.2% |
|
EXACT SCIENCES CORP | 1.2% |
|
MODERNA, INC. | 1.1% |
|
AMGEN INC | 1.1% |
 |
ROIVANT SCIENCES LTD. | 1.1% |
|
UNITED THERAPEUTICS CORP | 1.1% |
XBI Underweight Relative to CNCR
|
ACRIVON THERAPEUTICS, INC. | -2.6% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
GERON CORP | -1.9% |
|
JANUX THERAPEUTICS, INC. | -1.8% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
2SEVENTY BIO, INC. | -1.6% |
|
MERCK & CO. INC. | -1.5% |
|
LYELL IMMUNOPHARMA, INC. | -1.4% |
|
Y-MABS THERAPEUTICS, INC. | -1.4% |
 |
MORPHOSYS AG SPONSORED ADR | -1.4% |